1. Home
  2. HUT vs LGND Comparison

HUT vs LGND Comparison

Compare HUT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$61.71

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$192.60

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
LGND
Founded
2011
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
HUT
LGND
Price
$61.71
$192.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
6
Target Price
$54.29
$243.50
AVG Volume (30 Days)
5.1M
236.1K
Earning Date
03-02-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.76
EPS
1.89
2.49
Revenue
$178,318,000.00
$251,233,000.00
Revenue This Year
$74.79
$47.71
Revenue Next Year
$116.78
$9.77
P/E Ratio
$34.10
$76.38
Revenue Growth
5.60
64.83
52 Week Low
$10.04
$93.58
52 Week High
$66.07
$212.49

Technical Indicators

Market Signals
Indicator
HUT
LGND
Relative Strength Index (RSI) 61.64 46.14
Support Level $53.26 $188.13
Resistance Level $66.07 $207.06
Average True Range (ATR) 5.01 8.38
MACD 0.03 -0.75
Stochastic Oscillator 74.71 48.46

Price Performance

Historical Comparison
HUT
LGND

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: